Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
Citation
Colhoun , H M , Livingstone , S J , Looker , H C , Morris , A D , Wild , S H , Lindsay , R S , Reed , C , Donnan , P T , Guthrie , B , Leese , G P , McKnight , J , Pearson , D W M , Pearson , E , Petrie , J R , Philip , S , Sattar , N , Sullivan , F M , McKeigue , P & Scottish Diabetes Research Network (SDRN) Epidemiology group 2012 , ' Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs ' , Diabetologia , vol. 55 , no. 11 , pp. 2929-2937 . https://doi.org/10.1007/s00125-012-2668-0
Rights
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/3.0/